Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1847-58-1
2. Lathanol
3. Lathanol Lal
4. Nacconol Lal
5. Acetic Acid, Sulfo-, 1-dodecyl Ester, Sodium Salt
6. Sulfoacetic Acid Dodecyl Ester S-sodium Salt
7. Sodium 2-(dodecyloxy)-2-oxoethane-1-sulphonate
8. Sodium 2-(dodecyloxy)-2-oxoethanesulfonate
9. Acetic Acid, Sulfo-, Dodecyl Ester, S-sodium Salt
10. D0y70f2b9j
11. Herba Houttuyniae
12. Lathanol-lal 70
13. Dodecyl Sodium Sulfoacetate
14. Hsdb 7256
15. Dodecyl Sulfoacetate S-sodium Salt
16. Einecs 217-431-7
17. Unii-d0y70f2b9j
18. Sulfoacetic Acid 1-dodecyl Ester, Sodium Salt
19. Sulfoacetic Acid, 1-dodecyl Ester, Sodium Salt
20. Sodium Houttyfonate
21. Schembl121777
22. Dtxsid4027442
23. Bcp18547
24. Akos015900630
25. Sodium Lauryl Sulfoacetate, Aldrichcpr
26. Sodium;2-dodecoxy-2-oxoethanesulfonate
27. Ccg-267809
28. Db13157
29. Sodium Lauryl Sulfoacetate [ii]
30. Sodium Lauryl Sulfoacetate [hsdb]
31. Sodium Lauryl Sulfoacetate [inci]
32. Sodium Lauryl Sulfoacetate [vandf]
33. Sodium2-(dodecyloxy)-2-oxoethanesulfonate
34. Hy-107789
35. Sodium Lauryl Sulfoacetate [who-dd]
36. Cs-0030663
37. Ft-0657433
38. Na 2-(dodecyloxy)-2-oxoethane-1-sulphonate
39. H11025
40. W-109718
41. Q27275949
42. Acetic Acid, 2-sulfo-, Dodecyl Ester, Sodium Salt (1:1)
43. Sodium New Houttuyfonate Pound>>sodium Houttuyfonate Pound>>lathanol Lal Pound>>nacconol Lal
| Molecular Weight | 330.42 g/mol |
|---|---|
| Molecular Formula | C14H27NaO5S |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 14 |
| Exact Mass | 330.14768941 g/mol |
| Monoisotopic Mass | 330.14768941 g/mol |
| Topological Polar Surface Area | 91.9 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 338 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Sodium lauryl sulfoacetate is not an active pharmacological ingredient in pharmaceutical preparations and so has no official indication.
Sodium lauryl sulfoacetate acts as a wetting agent and surfactant in pharmaceutical preparations. It is currently used in enema-type laxatives.
B05XA02
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
Sodium lauryl Sulfoacetate can be absorbed through guinea pig skin. Two groups of 6 female weanling guinea pigs were immersed in either 0.2% aqueous sodium lauryl sulfoacetate or distilled water for 4 hr on 3 consecutive days. ... Seven blood samples were taken before and after each immersion and 24 hr after the final immersion. ....The blood concentrations of sodium lauryl sulfoacetate reached a maximum at the end of each immersion, which increased with each subsequent immersion.
Christian M, ed; J American College of Toxicology 6 (3): 261- 278 (1987)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
ABOUT THIS PAGE
A Sodium lauryl sulfoacetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium lauryl sulfoacetate, including repackagers and relabelers. The FDA regulates Sodium lauryl sulfoacetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium lauryl sulfoacetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sodium lauryl sulfoacetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sodium lauryl sulfoacetate supplier is an individual or a company that provides Sodium lauryl sulfoacetate active pharmaceutical ingredient (API) or Sodium lauryl sulfoacetate finished formulations upon request. The Sodium lauryl sulfoacetate suppliers may include Sodium lauryl sulfoacetate API manufacturers, exporters, distributors and traders.
click here to find a list of Sodium lauryl sulfoacetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sodium lauryl sulfoacetate DMF (Drug Master File) is a document detailing the whole manufacturing process of Sodium lauryl sulfoacetate active pharmaceutical ingredient (API) in detail. Different forms of Sodium lauryl sulfoacetate DMFs exist exist since differing nations have different regulations, such as Sodium lauryl sulfoacetate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sodium lauryl sulfoacetate DMF submitted to regulatory agencies in the US is known as a USDMF. Sodium lauryl sulfoacetate USDMF includes data on Sodium lauryl sulfoacetate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sodium lauryl sulfoacetate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sodium lauryl sulfoacetate suppliers with USDMF on PharmaCompass.
Sodium lauryl sulfoacetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium lauryl sulfoacetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium lauryl sulfoacetate GMP manufacturer or Sodium lauryl sulfoacetate GMP API supplier for your needs.
A Sodium lauryl sulfoacetate CoA (Certificate of Analysis) is a formal document that attests to Sodium lauryl sulfoacetate's compliance with Sodium lauryl sulfoacetate specifications and serves as a tool for batch-level quality control.
Sodium lauryl sulfoacetate CoA mostly includes findings from lab analyses of a specific batch. For each Sodium lauryl sulfoacetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium lauryl sulfoacetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium lauryl sulfoacetate EP), Sodium lauryl sulfoacetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium lauryl sulfoacetate USP).
LOOKING FOR A SUPPLIER?
